5
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Treatment of “Limited” Stage III Non-Small Cell Carcinoma of the Lung

, , , &
Pages 193-207 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (5)

Johan F Vansteenkiste, Paul R De Leyn, Georges J Deneffe, Tony E Lerut & Maurits G Demedts. (1998) Clinical prognostic factors in surgically treated stage IIIA-N2 non-small cell lung cancer: analysis of the literature. Lung Cancer 19:1, pages 3-13.
Crossref
Johan F. Vansteenkiste, Paul R. De Leyn, Georges J. Deneffe, Georges Stalpaert, Kris L. Nackaerts, Toni E. Lerut & Maurits G. Demedts. (1997) Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases. The Annals of Thoracic Surgery 63:5, pages 1441-1450.
Crossref
Robert T. Eagan. (1994) Management of Regionally Advanced (Stage III) Non-small Cell Lung Cancer. Chest 106:6, pages 340S-343S.
Crossref
Dirk E. Van Raemdonck, Airton Schneider & Robert J. Ginsberg. (1992) Surgical treatment for higher stage non-small cell lung cancer. The Annals of Thoracic Surgery 54:5, pages 999-1013.
Crossref
L. Penfield Faber & Philip D. Bonomi. (1990) Neoadjuvant treatment in locally advanced non-small cell lung cancer. Seminars in Surgical Oncology 6:5, pages 255-262.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.